Gene editing Archives

News and Trends 13 Sep 2016

Reviewing CRISPR, the Scientific Discovery of the Century

What's happening with CRISPR these days? Another company just filed for an IPO, documents relevant to CRISPR patent war have come to light, research is moving forward, and the therapy is…

September 13, 2016 - 8 minutesmins - By Evelyn Warner

deskgen desktop genetics biotech labiotech refresh crispr

News and Trends 5 Jul 2016

“CRISPR is highly fragmented, with too many approaches. We bring it all together”

The problem with CRISPR, is that not many people are actually experts in the field, and there are only a select few who worked on it pre-2013. So how did this…

July 5, 2016 - 4 minutesmins - By Dani Bancroft

crispr therapeutics gene editing labiotech refresh philip hemme biotech roger novak

News and Trends 1 Jun 2016

CRISPR Thx’ Founder: “We have over $250M in the bank”

So begins our series of videos documenting our biotech conference premier - Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading…

June 1, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 30 Nov 2015

Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”

CAR-T is solidifying in everybody's mind as the next revolution in Cancer treatment. But there is still a lot to do...That's basically what came out from my discussion with André…

November 30, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 6 Nov 2015

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

This week we leave the wonderful weather of Mallorca and head North, through France, England and across Hadrian's Wall where we land in the capital city of Scotland, Edinburgh. This…

November 6, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Oct 2015

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in the CAR-T campaign is to step away from personalised (autologous)…

October 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues. A UK expansion for Horizon is now underway, with the launch of a new genomics…

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2015

Francis Crick Institute pushes to do human embryo research

The Francis Crick Institute from London has announced its application to conduct non-clinical purpose research on human embryos. The Francis Crick Institute is a cutting-edge collaboration of the UK's leading…

September 22, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 17 Sep 2015

Welcome to the Golden age for Gene Editing!

Nuclease-based gene editing technology has opened up how biotechs approach genomic research in industry. A review by Boston Consulting Group explores the background to this excitingly complex field, highlighting how…

September 17, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 1 Jun 2015

DNA Therapeutics presents positive results for its breakthrough Advanced Cancer Therapy

ASCO Annual Meeting keeps bringing positive results of European companies that cross the ocean to present their clinical trial outcomes. DNA Therapeutics, the French biopharma, presented the results of the…

June 1, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Apr 2015

Desktop Genetics launches a new Gene Editing Platform

Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the Company’s earlier tools, and allows researchers to design genome editing vectors and cloning strategies optimized…

April 25, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 6 Apr 2015

Gene editing to make French fries less unhealthy

A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an average of €126M on the development of a genetically engineered crop (GMO), including €32M in…

April 6, 2015 - 4 minutesmins - By Cédric Brock

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering